Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes

Bei Zhang, Deborah Szalkowski, Elva D Diaz, Nancy Hayes, Roy Smith, Joel Berger

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Thiazolidinedione derivatives are insulin-sensitizing agents with proven antidiabetic activities in vivo. To explore the mechanism of action of this class of compounds, the effects of pioglitazone, CP-86,325, and AD-5075 on elements of the insulin signal transduction pathways were studied in Chinese hamster ovary cells overexpressing human insulin receptor (CHO-T) and L6 myotubes. In CHO-T cells, the binding of insulin to its receptor and the insulin-stimulated tyrosine kinase activity of the receptor were not altered by pioglitazone or CP-86,325. In contrast, treatment of CHO-T cells with the compounds resulted in significant increases in insulin-stimulated phosphatidylinositol (PI) 3-kinase activity. This insulin-enhancing effect was also observed in L6 myotubes treated with CP-86,325. The augmentations in kinase activity observed in CHO-T cells correlated with increases in the amount of PI 3-kinase (p85 subunit) in anti-phosphotyrosine immunoprecipitates of cell lysates. No gross changes in the tyrosine phosphorylation state of the insulin receptor substrate-1 were detected in insulin-stimulated CHO-T cells following treatment with the compounds. Furthermore, the compounds did not enhance insulin stimulation of mitogen- activated protein kinase or DNA synthesis in CHO-T cells. Thus, thiazolidinedione-derived antidiabetic agents may act as insulin sensitizers by augmenting insulin stimulation of PI 3-kinase activity in a rather specific manner.

Original languageEnglish (US)
Pages (from-to)25735-25741
Number of pages7
JournalJournal of Biological Chemistry
Volume269
Issue number41
StatePublished - Oct 14 1994
Externally publishedYes

Fingerprint

Phosphatidylinositol 3-Kinase
Skeletal Muscle Fibers
Cricetulus
Hypoglycemic Agents
Ovary
Cells
Insulin
T-cells
CHO Cells
pioglitazone
T-Lymphocytes
2,4-thiazolidinedione
human INSR protein
Insulin Receptor Substrate Proteins
Signal transduction
Phosphotyrosine
Phosphorylation
Insulin Receptor
Receptor Protein-Tyrosine Kinases
Mitogen-Activated Protein Kinases

ASJC Scopus subject areas

  • Biochemistry

Cite this

Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes. / Zhang, Bei; Szalkowski, Deborah; Diaz, Elva D; Hayes, Nancy; Smith, Roy; Berger, Joel.

In: Journal of Biological Chemistry, Vol. 269, No. 41, 14.10.1994, p. 25735-25741.

Research output: Contribution to journalArticle

@article{00eeb1c3dfa74301a66fa87eb03268e1,
title = "Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes",
abstract = "Thiazolidinedione derivatives are insulin-sensitizing agents with proven antidiabetic activities in vivo. To explore the mechanism of action of this class of compounds, the effects of pioglitazone, CP-86,325, and AD-5075 on elements of the insulin signal transduction pathways were studied in Chinese hamster ovary cells overexpressing human insulin receptor (CHO-T) and L6 myotubes. In CHO-T cells, the binding of insulin to its receptor and the insulin-stimulated tyrosine kinase activity of the receptor were not altered by pioglitazone or CP-86,325. In contrast, treatment of CHO-T cells with the compounds resulted in significant increases in insulin-stimulated phosphatidylinositol (PI) 3-kinase activity. This insulin-enhancing effect was also observed in L6 myotubes treated with CP-86,325. The augmentations in kinase activity observed in CHO-T cells correlated with increases in the amount of PI 3-kinase (p85 subunit) in anti-phosphotyrosine immunoprecipitates of cell lysates. No gross changes in the tyrosine phosphorylation state of the insulin receptor substrate-1 were detected in insulin-stimulated CHO-T cells following treatment with the compounds. Furthermore, the compounds did not enhance insulin stimulation of mitogen- activated protein kinase or DNA synthesis in CHO-T cells. Thus, thiazolidinedione-derived antidiabetic agents may act as insulin sensitizers by augmenting insulin stimulation of PI 3-kinase activity in a rather specific manner.",
author = "Bei Zhang and Deborah Szalkowski and Diaz, {Elva D} and Nancy Hayes and Roy Smith and Joel Berger",
year = "1994",
month = "10",
day = "14",
language = "English (US)",
volume = "269",
pages = "25735--25741",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "41",

}

TY - JOUR

T1 - Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes

AU - Zhang, Bei

AU - Szalkowski, Deborah

AU - Diaz, Elva D

AU - Hayes, Nancy

AU - Smith, Roy

AU - Berger, Joel

PY - 1994/10/14

Y1 - 1994/10/14

N2 - Thiazolidinedione derivatives are insulin-sensitizing agents with proven antidiabetic activities in vivo. To explore the mechanism of action of this class of compounds, the effects of pioglitazone, CP-86,325, and AD-5075 on elements of the insulin signal transduction pathways were studied in Chinese hamster ovary cells overexpressing human insulin receptor (CHO-T) and L6 myotubes. In CHO-T cells, the binding of insulin to its receptor and the insulin-stimulated tyrosine kinase activity of the receptor were not altered by pioglitazone or CP-86,325. In contrast, treatment of CHO-T cells with the compounds resulted in significant increases in insulin-stimulated phosphatidylinositol (PI) 3-kinase activity. This insulin-enhancing effect was also observed in L6 myotubes treated with CP-86,325. The augmentations in kinase activity observed in CHO-T cells correlated with increases in the amount of PI 3-kinase (p85 subunit) in anti-phosphotyrosine immunoprecipitates of cell lysates. No gross changes in the tyrosine phosphorylation state of the insulin receptor substrate-1 were detected in insulin-stimulated CHO-T cells following treatment with the compounds. Furthermore, the compounds did not enhance insulin stimulation of mitogen- activated protein kinase or DNA synthesis in CHO-T cells. Thus, thiazolidinedione-derived antidiabetic agents may act as insulin sensitizers by augmenting insulin stimulation of PI 3-kinase activity in a rather specific manner.

AB - Thiazolidinedione derivatives are insulin-sensitizing agents with proven antidiabetic activities in vivo. To explore the mechanism of action of this class of compounds, the effects of pioglitazone, CP-86,325, and AD-5075 on elements of the insulin signal transduction pathways were studied in Chinese hamster ovary cells overexpressing human insulin receptor (CHO-T) and L6 myotubes. In CHO-T cells, the binding of insulin to its receptor and the insulin-stimulated tyrosine kinase activity of the receptor were not altered by pioglitazone or CP-86,325. In contrast, treatment of CHO-T cells with the compounds resulted in significant increases in insulin-stimulated phosphatidylinositol (PI) 3-kinase activity. This insulin-enhancing effect was also observed in L6 myotubes treated with CP-86,325. The augmentations in kinase activity observed in CHO-T cells correlated with increases in the amount of PI 3-kinase (p85 subunit) in anti-phosphotyrosine immunoprecipitates of cell lysates. No gross changes in the tyrosine phosphorylation state of the insulin receptor substrate-1 were detected in insulin-stimulated CHO-T cells following treatment with the compounds. Furthermore, the compounds did not enhance insulin stimulation of mitogen- activated protein kinase or DNA synthesis in CHO-T cells. Thus, thiazolidinedione-derived antidiabetic agents may act as insulin sensitizers by augmenting insulin stimulation of PI 3-kinase activity in a rather specific manner.

UR - http://www.scopus.com/inward/record.url?scp=0028032417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028032417&partnerID=8YFLogxK

M3 - Article

C2 - 7929278

AN - SCOPUS:0028032417

VL - 269

SP - 25735

EP - 25741

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 41

ER -